IL6 and neoplasm: Mechanistically, when miR-155-5p is delivered from M2 macrophages to colon cancer cells via exosomes, it disrupts the ability of ZC3H12B to reduce the stability of IL-6, resulting in immune evasion and tumor formation [111].